Summit Therapeutics SMMT New Jersey And California — Total lease payments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue.
The source filing: Summit Therapeutics’s 10-K, filed February 23, 2026.
- Filed
- Feb 23, 2026, 4:10 PM EST
- Fiscal year
- FY2025
- Accession
- 0001599298-26-000015
During the year ended December 31, 2025, the Company recorded $17,056 of operating right-of-use assets and operating lease liabilities related to new leases for office space for its Palo Alto, CA and Princeton, NJ locations. Total future lease payments as of December 31, 2025 are approximately $23,117 on an undiscounted basis. The Palo Alto lease commenced on December 1, 2025 and has a term of approximately 8 years. The Princeton, NJ lease commenced on August 18, 2025 and has a term of 3 years. The Company recorded $4,216 of right-of-use assets during the year ended December 31, 2024 related to its Miami, Florida headquarters.
Item 16. Report Summary
FAQ
- What is Summit Therapeutics's new jersey and california — total lease payments?
- Summit Therapeutics (SMMT) reported new jersey and california — total lease payments of $23.12M in Q4 2025.
- What does new jersey and california — total lease payments mean?
- This metric captures the aggregate cash outflows associated with operating and finance lease obligations for the specified geographic segment. It encompasses rent for office space, laboratory facilities, and other leased equipment necessary for regional operations. Monitoring this helps assess the fixed overhead burden and the cash flow impact of maintaining a physical presence in these high-cost operational areas.
Ask your AI about Summit Therapeutics's new jersey and california — total lease payments.
Connect your AI assistant and compare it to peers, right in your chat.
